Clinical Trial Update: Effectiveness of Dalteparin Therapy as Intervention in Recurrent Pregnancy Loss [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating dalteparin therapy for recurrent pregnancy loss has completed, with results on effectiveness reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pregnancy Loss

Drugs mentioned

• Dalteparin (dalteparin)

Snippet

Sponsor: University of Jena | Conditions: Abortion, Habitual | Phase 3 | Status: COMPLETED